UPDATED: AstraZeneca CEO Soriot bets up to $7B on a major league collaboration for a game-changing HER2 cancer drug - Endpoints News
UPDATED: AstraZeneca CEO Soriot bets up to $7B on a major league collaboration for a game-changing HER2 cancer drug Endpoints News
After years of out-licensing, product sales and whatever else it took to float the sinking AstraZeneca ship, CEO Pascal Soriot is now a buyer. And he's going big.
View full coverage on Google News
UPDATED: AstraZeneca CEO Soriot bets up to $7B on a major league collaboration for a game-changing HER2 cancer drug - Endpoints News
Reviewed by Geeky Gadgets
on
07:17
Rating:
No comments: